Ajay Manhapra1, Robert Rosenheck. 1. VA Hampton Medical Center, Hampton, VA (AM); VA New England Mental Illness Research and Education Center, West Haven, CT (AM, RR); Department of Psychiatry, Yale School of Medicine, New Haven, CT (AM, RR).
Abstract
INTRODUCTION: Very little is known of the behavioral vulnerabilities of patients diagnosed with smoking-related chronic medical illness who continue to smoke, potentially worsening morbidity and mortality risks. This study explores the association of tobacco use disorder (TUD) among those with smoking-related chronic medical illnesses with other substance use disorders (SUDs) and risk factors. METHODS: Among veterans with smoking-related chronic medical illnesses identified from the National Veterans Health Administration administrative records from fiscal year 2012, we compared the characteristics of those with a diagnosis of TUD (International Classification of Diseases, 9th edition code 305.xx; n = 519,918), and those without such a diagnosis (n = 2,691,840). Using multiple logistic regression, we further explored the independent association of factors associated with TUD. RESULTS: SUD prevalence was markedly higher among those with TUD (24.9% vs 5.44%), including alcohol use disorder (20.4% vs 4.3%) and drug use disorder (13.5% vs 2.6%), compared with nonsmokers. On multiple logistic regression analyses, alcohol use disorder (odds ratio [OR] 2.94, 95% confidence interval [CI] 2.90-2.97) and drug use disorder (OR 1.97, 95% CI 1.94-1.99) were independently associated with current TUD diagnosis. Having any single SUD was associated with considerably high odds of having TUD (OR 3.32, 95% CI 3.29-2.36), and having multiple SUDs with even further increased risk (OR 4.09, 95% CI 4.02-4.16). CONCLUSIONS: A substantial proportion of people with TUD diagnosis despite concurrent smoking-related medical illnesses are also likely to have other comorbid SUDs, complicating efforts at smoking cessation, and requiring a broader approach than standard nicotine-dependence interventions.
INTRODUCTION: Very little is known of the behavioral vulnerabilities of patients diagnosed with smoking-related chronic medical illness who continue to smoke, potentially worsening morbidity and mortality risks. This study explores the association of tobacco use disorder (TUD) among those with smoking-related chronic medical illnesses with other substance use disorders (SUDs) and risk factors. METHODS: Among veterans with smoking-related chronic medical illnesses identified from the National Veterans Health Administration administrative records from fiscal year 2012, we compared the characteristics of those with a diagnosis of TUD (International Classification of Diseases, 9th edition code 305.xx; n = 519,918), and those without such a diagnosis (n = 2,691,840). Using multiple logistic regression, we further explored the independent association of factors associated with TUD. RESULTS: SUD prevalence was markedly higher among those with TUD (24.9% vs 5.44%), including alcohol use disorder (20.4% vs 4.3%) and drug use disorder (13.5% vs 2.6%), compared with nonsmokers. On multiple logistic regression analyses, alcohol use disorder (odds ratio [OR] 2.94, 95% confidence interval [CI] 2.90-2.97) and drug use disorder (OR 1.97, 95% CI 1.94-1.99) were independently associated with current TUD diagnosis. Having any single SUD was associated with considerably high odds of having TUD (OR 3.32, 95% CI 3.29-2.36), and having multiple SUDs with even further increased risk (OR 4.09, 95% CI 4.02-4.16). CONCLUSIONS: A substantial proportion of people with TUD diagnosis despite concurrent smoking-related medical illnesses are also likely to have other comorbid SUDs, complicating efforts at smoking cessation, and requiring a broader approach than standard nicotine-dependence interventions.
Authors: Joanne M Murabito; Jane C Evans; Kenneth Nieto; Martin G Larson; Daniel Levy; Peter W f Wilson Journal: Am Heart J Date: 2002-06 Impact factor: 4.749
Authors: Jason T Newsom; Nathalie Huguet; Michael J McCarthy; Pamela Ramage-Morin; Mark S Kaplan; Julie Bernier; Bentson H McFarland; Jillian Oderkirk Journal: J Gerontol B Psychol Sci Soc Sci Date: 2011-10-09 Impact factor: 4.077
Authors: Mark S Walker; Damon J Vidrine; Ellen R Gritz; Randy J Larsen; Yan Yan; Ramaswamy Govindan; Edwin B Fisher Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-11-28 Impact factor: 4.254
Authors: Uma S Nair; Melanie L Bell; Nicole P Yuan; Betsy C Wertheim; Cynthia A Thomson Journal: Public Health Rep Date: 2018 Mar/Apr Impact factor: 2.792
Authors: Solomon A Graf; Steven B Zeliadt; Peter J Rise; Leah M Backhus; Xiao-Hua Zhou; Emily C Williams Journal: J Thorac Dis Date: 2018-03 Impact factor: 2.895
Authors: Vitalina Bashynska; Alexander Koliada; Kateryna Murlanova; Oksana Zahorodnia; Yuliia Borysovych; Vladyslav Moseiko; Oleh Lushchak; Alexander Vaiserman Journal: Genet Res Int Date: 2019-10-20